Literature DB >> 221581

Hypocomplementemia associated with naturally occurring lymphosarcoma in pet cats.

L Kobilinsky, W D Hardy, N K Day.   

Abstract

Eighty cats were classified by indirect immunofluorescence and histologic diagnosis into four categories: normal, feline leukemia virus (FeLV) infected; normal noninfected; lymphosarcoma-FeLV infected; lymphosarcoma, no FeLV present. All viremic cats with lymphosarcoma were found to be hypocomplementemic and activation of the complement system had occurred via the classical pathway. Sera of cats with lymphosarcoma in the absence of FeLV had varying levels of total hemolytic complement (TCH50) ranging from normal to hypocomplementemic. Approximately 50% of the cats that were viremic but histologically and clinically free of disease had TCH50 levels within normal range, and the remainder exhibited varying degrees of hypocomplementemia.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221581

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Delineation of two defects responsible for T-cell hyporesponsiveness to concanavalin A in MRL congenic mice.

Authors:  R Cameron; J D Waterfield
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

2.  Effects of cobra venom factor treatment on latent feline leukemia virus infection.

Authors:  E H Kraut; J L Rojko; R G Olsen; D L Tuomari
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

Review 3.  Immunopathology induced by the feline leukemia virus.

Authors:  W D Hardy
Journal:  Springer Semin Immunopathol       Date:  1982

4.  Clinicopathologic responses in cats with feline leukemia virus-associated leukemia-lymphoma treated with staphylococcal protein A.

Authors:  R W Engelman; R D Tyler; L Q Trang; W T Liu; R A Good; N K Day
Journal:  Am J Pathol       Date:  1985-03       Impact factor: 4.307

5.  Detection of tumour associated antigen in eluates from protein A columns used for ex vivo immunoadsorption of plasma from melanoma patients by radioimmunoassay.

Authors:  R K Gupta; A M Leitch; D L Morton
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

6.  In vitro activation of feline complement by feline leukemia virus.

Authors:  L Kobilinsky; W D Hardy; R Ellis; S S Witkin; N K Day
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

Review 7.  Feline leukemia/sarcoma viruses and immunodeficiency.

Authors:  J Rojko; M Essex; Z Trainin
Journal:  Adv Vet Sci Comp Med       Date:  1988

8.  Influence of thymic genotype on the systemic lupus erythematosus-like disease and T cell proliferation of MRL/Mp-lpr/lpr mice.

Authors:  A N Theofilopoulos; R S Balderas; D L Shawler; S Lee; F J Dixon
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.